GLP-1 diabetes meds may curb worsening anxiety and depression, study finds
TL;DR
A large Swedish study of about 95,000 people with depression or anxiety who were taking diabetes medications found that GLP-1 receptor agonists—especially semaglutide and liraglutide—were associated with a lower risk of worsening mental health outcomes such as hospitalizations, sick leave, self-harm, or death, while other GLP-1 drugs did not show the same benefit; experts caution about drawing causality from observational data. A separate Danish study linked first-trimester exposure to semaglutide or liraglutide for diabetes with a higher risk of preterm birth.
- GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds The Guardian
- Study Shows Ozempic Is Linked to Lower Risk of Worsening Mental Health Issues Bloomberg.com
- GLP-1s Tied to Lower Risk of Psychiatric Decline in Pre-existing Mental Illness Medscape
- GLP-1 medications used to treat diabetes and obesity may also help alleviate symptoms of anxiety and depression Medical Xpress
- Study reveals weight-loss jabs may alleviate symptoms of anxiety and depression The Independent
Want the full story? Read the original reporting
Read on The Guardian